Created with Sketch.
MAP - Market Access Podcast
28 minutes | Oct 15, 2021
Prof. Dr. David Matusiewicz & Dr. Anne Sophie Geier - 1 year DIGAs. Is the "fast track process" for digital health applications successful?
In this Podcast episode, Dr. Stefan Walzer is reflecting on 1 year DIGAswith the leading question whether the "fast track process" for digital health applications is successful?Additionally, the two digital health experts, Prof. Dr. David Matusiewicz from the FOM Universtity and Dr. Anne Sophie Geier from the head association of digital healthcare SVDGV, will also discuss the status of digitalization in the German health care system.Get into the latest digital health care discussions and let us know in case you might have any questions.Take the chance to stay connected and subscribe with your favorite podcasting platform.For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
34 minutes | Oct 1, 2021
Remo Christen – Early paid access in Switzerland – Switzerland, wonderland??
In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement specifics including the famous article 71, which allows an early paid access. Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate. In this episode, listeners will learn the specifics of the Swiss culture, the reimbursement process also in comparison to the German AMNOG and why Switzerland is attractive for drug launches.Subscribe with your favorite podcasting platform. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
36 minutes | Sep 15, 2021
Prof. Dr. Wagschal - What can we expect from the upcoming elections in Germany?
In this Podcast episode, Dr. Stefan Walzer is speaking to Prof. Dr. Wagschal from the University of Freiburg about the upcoming elections in Germany.They are discussing latest forecasts and potential policy implications. Prof. Wagschal also explains limitations of forecasts and dynamics of recent elections.Another important part is in the potential (new) coalitions and their likely impact on the health care market.Subscribe at your favourite podcasting platform and for more information about MArS Market Access and Pricing Strategy visit:marketaccess-pricingstrategy.de
34 minutes | Sep 2, 2021
Dr. Mathias Flume - AMNOG will change in 2022, but how?
In this Podcast episode, Dr. Stefan Walzer is talking with Dr. Mathias Flume about the AMNOG process as well as interesting details about the market access process in Germany.Mathias is a core stakeholder within the regional payer system in Germany at one of the most innovative Statutory Health Insurance Physician Associations (KV Westphalia-Lippe). Mathias brings the payer view into the discussion of 10 years AMNOG. Success or failure?
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021